• LinkedIn
• RSS

In Memory of Our Co-Founder Dr. Melanie Tallent                 NIH Grant Awarded ($670 K) to further Development of Drug to Treat Dravet Syndrome                 NIH Grant Awarded ($340K) for Initial Drug Development of a Novel Alzheimer’s Disease Treatment.                 AMPA GluA1-flip targeted oligonucleotide therapy paper published in PLOS One Journal